New Fizik Lyra shoe brings pro-level features to a more palatable price point
Double Li2 dials, a breathable upper, and a wider toebox make for an attractive upgrade this summer
Cycling Weekly ·
Get all your news in one place.
100's of premium titles.
One app.
Start reading
One app.
Get all your news in one place.
100's of premium titles. One news app.
The Latest Breaking News from Lyra
Fizik’s new Lyra shoe is designed for 'modern riding positions', but what does that mean and is it even needed?
New shoes bring aesthetics and tech from Fizik’s top spec shoes to a lower price, with a wider toe box and lower drop
Cycling News ·
Hollyland launches its first webcam, and it looks incredible!
This 4K webcam uses a sensor that is bigger than most and can be paired with a wireless mic
Digital Camera World ·
From analysis to the latest developments in health,
read the most diverse news in one place.
read the most diverse news in one place.
Read news from The Economist, FT, and more,
with one subscription
with one subscription
Lyra Therapeutics's Return On Capital Employed Insights
According to data from Benzinga Pro, during Q1, Lyra Therapeutics's (NASDAQ:LYRA) reported sales totaled $5.37 million. Despite a 48.51% increase in earnings, the company posted a loss of $7.01 million.
Benzinga ·
25 huge gigs happening in Ireland this summer including Red Hot Chili Peppers, Elton John and more
It was hard to narrow it down to just 25, but here are some of the biggest concerts to catch over the next few months.
Irish Mirror ·
Peak Sales Potential For This ENT-Focused Stock Is Under-Appreciated, Says Cantor
Cantor initiated coverage on Lyra Therapeutics Inc (NASDAQ:LYRA) with an Overweight rating and a price target of $15 (166% upside). According to the analyst, Lyra product pipeline's peak sales potential is under-appreciated, and it expects upward earnings estimate revisions to potentially move LYRA's stock higher. LYRA is well-positioned with a portfolio of products to…
Benzinga ·
Recap: Lyra Therapeutics Q1 Earnings
Lyra Therapeutics (NASDAQ:LYRA) reported its Q1 earnings results on Tuesday, May 10, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Benzinga ·
28 Stocks Moving In Friday's Mid-Day Session
Gainers
Lyra Therapeutics, Inc. (NASDAQ: LYRA) shares climbed 33.3% to $5.78 as the company reported a private placement for gross proceeds of $110.5 million.
Benzinga ·
Lyra Therapeutics Stock Surges On Equity Raise Of $100M
Lyra Therapeutics Inc (NASDAQ:LYRA) has announced a private placement of approximately $100.5 million. The Company has offered 18.8 million common shares at $4.22 per share and pre-funded warrants to purchase an aggregate of 5 million shares with an exercise price of $0.001 per share, at $4.219 per share. Each pre-funded warrant will…
Benzinga ·
Coverage From
Benzinga
Cycling News
Cycling Weekly
Digital Camera World
Evening Standard
Irish Mirror
T3
The National (Scotland)
People
From analysis to the latest developments in health,
read the most diverse news in one place.
read the most diverse news in one place.
Organisations
Nasdaq
22,825 stories
NYSE
19,908 stories
FDA
7,755 stories
John Lewis
2,669 stories
Guns N Roses
550 stories
Merck
381 stories
Westlife
302 stories
Green Day
288 stories
NetAPorter
267 stories
Red Hot Chili Peppers
219 stories
Govee
170 stories
Ganni
161 stories
Jigsaw
132 stories
Duran Duran
130 stories
Health Canada
124 stories
Pixies
111 stories
CMAT
102 stories
ME
94 stories
Fizik
93 stories
Dôen
64 stories
Read news from The Economist, FT, and more,
with one subscription
with one subscription
Topics
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.
100+ trusted global sources.
